CTI-BIOTECH

CTIBIOTECH™ is a preclinical innovative CRDMO developing human cell-based bio-assays and realistic tissue/NAM models in the fields of cancer research, skin biology for dermo-cosmetics and stem cells/regenerative medicine. CTIBIOTECH™ is a pioneer and a world leader in the production of human tissues and bioassays using 3D bioprinting and additive manufacturing for biomedical, pharmaceutical, and dermatocosmetics research and development

CTIBIOTECH™ perfected, optimized and developed bespoke human tissue engineering technologies, and masters 3 methods to produce predictive bioassays based on human cells:

->"Ex vivo" 3D human tissue culture: by testing directly on freshly resected tissue (skin, tumor, liver) following surgery or diagnosis (skin, blood, tumors, etc.)

->2D "in vitro" primary cell models: expertise human primary cell line production (immune cells, stem cells, cancer cells, liver cells, neuronal cells, skin cells, etc.) from fresh tissue for 2D bioassays

->3D bioprinting of human tissue: revolutionary technology enabling the industrialization of bioassay production, a faster, more accurate, reproducible, and highly automated process (10 years of R&D work carried out by CTIBIOTECH™). The result is a predictive 3D biological tissue structure composed of human cells that enables more reliable and cost-effective testing

"Do it yourself"

Human cells and tissue bioassay products: turnkey high value technology solutions delivered to academic and industrial laboratories worldwide.

"We do it for you and with you"

Contract research and open innovation contract: for preclinical and clinical development for efficacy, potency and safety validation applied to biomedicine, pharmaceutical and dermatocosmetics R&D.